Pharmaceutical intelligence for pharmaceutical companies involved in mental health with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.

Signals: 1
Catalysts: 0
Assets: 1

Recent signals(1)

ClinicalJuly 9, 2026

Adapting STAIR-NT for Polysubstance Users in Opioid Treatment Programs

The STAIR-NT intervention was adapted for patients using stimulants and opioids, showing promise in meeting treatment needs.

Upcoming catalysts

No catalysts indexed for this entity yet.

Regulatory activity

No signals indexed for this entity yet.

Clinical activity(1)

ClinicalJuly 9, 2026

Adapting STAIR-NT for Polysubstance Users in Opioid Treatment Programs

The STAIR-NT intervention was adapted for patients using stimulants and opioids, showing promise in meeting treatment needs.

Competitive activity

No signals indexed for this entity yet.

Assets

Adapting →

Therapeutic areas

Mental Health →

PTSD →

Indications

No related entities indexed yet.

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.